Myocardial Infarction Research

Myocardial infarction (MI) - more commonly referred to as a heart attack - is an acute event caused by the interruption of blood supply to regions of the heart, leading to myocardial necrosis. Infarction of a substantial area of the myocardium can disrupt normal conductance of the heart, leading to cardiac arrest.In the majority of cases, an MI is immediately preceded by the presence of an occlusive thrombus within a coronary artery, blocking blood flow to the downstream tissue. The most common cause of an occlusive thrombus within a coronary artery is the rupture of an atherosclerotic plaque. However, the occlusion of a coronary artery may also result from coronary embolism. This can occur in patients following stent placement, angioplasty, and coronary artery bypass grafting.

Myocardial Infarction Research Products Targets

Products for Myocardial Infarction Research - Page 11

  1. Cat.No. Product Name Information/Activity
  2. BCC5675 ICI 174,864 89352-67-0 ICI 174,864 chemical structure
  3. BCC5683 Naltriben mesylate 122517-78-6 Naltriben mesylate chemical structure
  4. BCC7054 SDM25N hydrochloride 342884-71-3 SDM25N hydrochloride chemical structure
  5. BCC7068 BMY 45778 Non-prostanoid prostacyclin IP receptor partial agonist BMY 45778 chemical structure
  6. BCC7315 (±)-Cloprostenol sodium salt Cloprostenol sodium salt (ICI 80996 sodium salt) is a potent synthetic prostaglandin analogue, acts as a luteolytic agent, and is a PGF2α receptor agonist. (±)-Cloprostenol sodium salt chemical structure
  7. BCC7843 16,16-Dimethyl Prostaglandin E2 16,16-Dimethyl prostaglandin E2 (16,16-dimethyl PGE2) is an orally active vertebrate Hematopoietic stem cells (HSCs) homeostasis critical regulator. 16,16-Dimethyl prostaglandin E2 can act through EP2/EP4 and has an interaction with the Wnt pathway. 16,16-Dimethyl Prostaglandin E2 chemical structure
  8. BCC7534 Epoprostenol Epoprostenol sodium (Prostaglandin I2 (sodium salt)), the synthetic form of the natural prostaglandin derivative prostacyclin (prostaglandin I2), is registered worldwide for the treatment of Pulmonary arterial hypertension (PAH). Epoprostenol sodium is used in pulmonary hypertension and transplantation as a potent inhibitor of platelet aggregation. Epoprostenol chemical structure
  9. BCC7247 Iloprost Iloprost (ZK 36374) is a synthetic analogue of prostacyclin PGI2. Iloprost chemical structure
  10. BCC5240 Misoprostol 59122-46-2 Misoprostol chemical structure
  11. BCC7316 Prostaglandin E2 Prostaglandin E2 is a hormone-like substance that participate in a wide range of body functions such as the contraction and relaxation of smooth muscle, the dilation and constriction of blood vessels, control of blood pressure, and modulation of inflammation. Prostaglandin E2 chemical structure

Items 101 to 110 of 400 total